A phase III study to determine the breast cancer risk-reducing effect of denosumab in women carrying a pathogenic germline BRCA1 variant (The BRCA-P Study)

Rachel Michaelson-Cohen, Joan Brunet, Rita Katharina Schmutzler, D. Gareth Evans,Michael Gnant, Dominik Hlauschek, Aleksandra Mystek,Nizar Bhulani,Geoff Lindeman, Christian Singer,Judy Garber

EUROPEAN JOURNAL OF HUMAN GENETICS（2024）

Cited 0|Views4

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined